{"pmid":32478707,"title":"Cuba's Pedro Kouri Tropical Medicine Institute:Battling COVID-19 One Study, One Test, One Patient at a Time.","text":["Cuba's Pedro Kouri Tropical Medicine Institute:Battling COVID-19 One Study, One Test, One Patient at a Time.","This MEDICC Review roundtable brings you specialists from Havana's Pedro Kouri Tropical Medicine Institute (IPK), who are working directly with testing, research and patient care during the COVID-19 pandemic. Founded in 1937 by its namesake, the Institute has gained considerable worldwide prestige. Today, it is a PAHO-WHO Collaborating Center for the Study of Dengue and Its Vector, and for the Elimination of Tuberculosis. Its main role within Cuba's health system is as the national reference center for prevention, control, management and elimination of infectious diseases, including epidemics. Its 479 workers staff 32 departments, including laboratories, research and teach-ing facilities, a hospital and isolation center. The IPK's hospital treats later-stage AIDS patients, while the Institute is the nation-al reference center for attention to all HIV-positive patients and maintains the national HIV/AIDS registry, as well as registries for other infectious diseases. The institution was responsible for training the Cuban doctors who served in West Africa during the 2014-2016 Ebola outbreaks and for those going abroad to assist in the COVID-19 response today, and its professionals offer an internationally-recognized biennial course on dengue.","MEDICC Rev","Coutin, Gisele","Bacallao-Gallestey, Jorge","Castellanos-Serra, Lila","32478707"],"abstract":["This MEDICC Review roundtable brings you specialists from Havana's Pedro Kouri Tropical Medicine Institute (IPK), who are working directly with testing, research and patient care during the COVID-19 pandemic. Founded in 1937 by its namesake, the Institute has gained considerable worldwide prestige. Today, it is a PAHO-WHO Collaborating Center for the Study of Dengue and Its Vector, and for the Elimination of Tuberculosis. Its main role within Cuba's health system is as the national reference center for prevention, control, management and elimination of infectious diseases, including epidemics. Its 479 workers staff 32 departments, including laboratories, research and teach-ing facilities, a hospital and isolation center. The IPK's hospital treats later-stage AIDS patients, while the Institute is the nation-al reference center for attention to all HIV-positive patients and maintains the national HIV/AIDS registry, as well as registries for other infectious diseases. The institution was responsible for training the Cuban doctors who served in West Africa during the 2014-2016 Ebola outbreaks and for those going abroad to assist in the COVID-19 response today, and its professionals offer an internationally-recognized biennial course on dengue."],"journal":"MEDICC Rev","authors":["Coutin, Gisele","Bacallao-Gallestey, Jorge","Castellanos-Serra, Lila"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478707","source":"PubMed","week":"202023|Jun 01 - Jun 07","locations":["Havana","Cuba","Cuban","West Africa","Cuba"],"countries":["Cuba"],"countries_codes":["CUB|Cuba"],"topics":["Prevention"],"weight":1,"_version_":1668437835120640001,"score":9.490897,"similar":[{"pmid":32478709,"title":"Stemming COVID-19 in Cuba: Strengths, Strategies, ChallengesFrancisco Duran MD.","text":["Stemming COVID-19 in Cuba: Strengths, Strategies, ChallengesFrancisco Duran MD.","Dr Duran is a native of eastern San-tiago de Cuba and his early medical career began in this mountainous re-gion, where he also headed provin-cial prevention and treatment of HIV/AIDS. He went on to become rector of the Medical University of Santiago de Cuba and provincial health direc-tor. Later in Havana, Dr Duran was director of medical education and vice minister at the Ministry of Public Health (MINSAP). Abroad, he served as advisor to Angola's Minister of Health, and on his return, as deputy director of Cuba's Pedro Kouri Tropical Medicine Institute (IPK). Dr Duran has been \"battle-tested\" over the years by his involvement in stemming dengue epidemics and other infectious dis-ease outbreaks, good preparation for his current position as National Direc-tor of Epidemiology. Today, his is the voice and the face on the 11:00 AM briefing carried daily by Cuban television, reporting the latest data on the un-folding COVID-19 pandemic globally, in the Americas and.","MEDICC Rev","Reed, Gail","32478709"],"abstract":["Dr Duran is a native of eastern San-tiago de Cuba and his early medical career began in this mountainous re-gion, where he also headed provin-cial prevention and treatment of HIV/AIDS. He went on to become rector of the Medical University of Santiago de Cuba and provincial health direc-tor. Later in Havana, Dr Duran was director of medical education and vice minister at the Ministry of Public Health (MINSAP). Abroad, he served as advisor to Angola's Minister of Health, and on his return, as deputy director of Cuba's Pedro Kouri Tropical Medicine Institute (IPK). Dr Duran has been \"battle-tested\" over the years by his involvement in stemming dengue epidemics and other infectious dis-ease outbreaks, good preparation for his current position as National Direc-tor of Epidemiology. Today, his is the voice and the face on the 11:00 AM briefing carried daily by Cuban television, reporting the latest data on the un-folding COVID-19 pandemic globally, in the Americas and."],"journal":"MEDICC Rev","authors":["Reed, Gail"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478709","source":"PubMed","week":"202023|Jun 01 - Jun 07","locations":["San-tiago","Cuba","Havana","Angola","Cuba","Cuban","Cuba"],"countries":["Cuba","Angola"],"countries_codes":["CUB|Cuba","AGO|Angola"],"weight":0,"_version_":1668437835105959936,"score":612.95605},{"pmid":32478705,"title":"Bringing Cuban Biotech Research to Bear on COVID-19:All Hands and Minds on Deck.","text":["Bringing Cuban Biotech Research to Bear on COVID-19:All Hands and Minds on Deck.","This MEDICC Review roundtable gathers some of Cuba's top researchers in the fi elds of vaccines and biotechnology, all of whom work in institutions belonging to BioCubaFarma, the umbrella company of Cuban biotech and pharmaceutical R&D, production, distribution and export. Founded in 2012, the company is comprised of 34 enterprises with 61 lines of production and some 20,000 employees. A total of 765 of its products are registered in 53 countries and exported to an-other 50. Its scientists' research has resulted in 2640 patents in Cuba and globally.","MEDICC Rev","Castellanos-Serra, Lila","32478705"],"abstract":["This MEDICC Review roundtable gathers some of Cuba's top researchers in the fi elds of vaccines and biotechnology, all of whom work in institutions belonging to BioCubaFarma, the umbrella company of Cuban biotech and pharmaceutical R&D, production, distribution and export. Founded in 2012, the company is comprised of 34 enterprises with 61 lines of production and some 20,000 employees. A total of 765 of its products are registered in 53 countries and exported to an-other 50. Its scientists' research has resulted in 2640 patents in Cuba and globally."],"journal":"MEDICC Rev","authors":["Castellanos-Serra, Lila"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478705","source":"PubMed","week":"202023|Jun 01 - Jun 07","locations":["Cuba","Cuban","Cuba"],"countries":["Cuba"],"countries_codes":["CUB|Cuba"],"weight":0,"_version_":1668437835195088896,"score":324.62518},{"pmid":32478711,"title":"COVID-19 Case Detection: Cuba's Active Screening Approach.","text":["COVID-19 Case Detection: Cuba's Active Screening Approach.","Meningitis, neuropathy, HIV, dengue-since the 1960s, Cuba has faced its share of epidemics. More recently, Cuban health pro-fessionals tackled domestic outbreaks of H1N1 (2009) and Zika (2016), and worked alongside colleagues from around the world to stem Ebola in West Africa; all three were categorized by WHO as public health emergencies of international concern. In December 2019, China reported its fi rst cluster of pneumo-nia cases, later identifi ed as the novel coronavirus disease COVID-19. In January 2020, Cuban authorities convened a multi-sector working group coordinated by the Ministry of Pub-lic Health (MINSAP) and Civil Defense to tailor its national epi-demic control plan to confront the rapidly-spreading disease. The plan features a national reporting system and database, with standard protocols including early case detection, contact tracing and regularly-scheduled public health messaging. In late January, no fewer than six ministries, plus the National Sports and Recreation Institute, Customs, Immigration and national media outlets, came together to adapt domestic proto-cols and design multi-phase control and response mechanisms to combat the SARS-CoV-2 virus.","MEDICC Rev","Gorry, Conner","32478711"],"abstract":["Meningitis, neuropathy, HIV, dengue-since the 1960s, Cuba has faced its share of epidemics. More recently, Cuban health pro-fessionals tackled domestic outbreaks of H1N1 (2009) and Zika (2016), and worked alongside colleagues from around the world to stem Ebola in West Africa; all three were categorized by WHO as public health emergencies of international concern. In December 2019, China reported its fi rst cluster of pneumo-nia cases, later identifi ed as the novel coronavirus disease COVID-19. In January 2020, Cuban authorities convened a multi-sector working group coordinated by the Ministry of Pub-lic Health (MINSAP) and Civil Defense to tailor its national epi-demic control plan to confront the rapidly-spreading disease. The plan features a national reporting system and database, with standard protocols including early case detection, contact tracing and regularly-scheduled public health messaging. In late January, no fewer than six ministries, plus the National Sports and Recreation Institute, Customs, Immigration and national media outlets, came together to adapt domestic proto-cols and design multi-phase control and response mechanisms to combat the SARS-CoV-2 virus."],"journal":"MEDICC Rev","authors":["Gorry, Conner"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478711","source":"PubMed","week":"202023|Jun 01 - Jun 07","locations":["Cuba","Cuban","West Africa","China","Cuban","Cuba"],"countries":["China","Cuba"],"countries_codes":["CHN|China","CUB|Cuba"],"topics":["Prevention"],"weight":1,"_version_":1668532089572556800,"score":323.5413},{"pmid":32478713,"title":"US Physicians Trained in Cuba Battle COVID-19 at Home:A Personal Account from the New York City Epicenter.","text":["US Physicians Trained in Cuba Battle COVID-19 at Home:A Personal Account from the New York City Epicenter.","Speaking remotely with US graduates of Havana's Latin American School of Medicine (ELAM), I found them at work on hospital floors, in ICUs and health centers across the United States, putting their professional and personal commitment to the test against COVID-19. Nowhere was that more evident than in New York City, the disease's epicenter, where one grad told me virtually every hospital has at least one MD from the Cuban school, which has provided free 6-year medical training for some 30,000 doctors since the school's founding in 1999. The student body comes primarily from low- and middle-income countries worldwide, but Cuba also provided 200 US students with scholarships. One of them is Dr Joaquin Morante (ELAM Class of 2012), who did his medical residency in internal medicine, followed by fellowships in pulmonary disease and critical care medicine. Triple-licensed in internal medicine, pulmonary and critical care medicine, he is now an attending physician on staff at Jacobi Medical Center in The Bronx, one of New York City's public hospitals, and considered a 'hot spot' due to its COVID-19 caseload. I spoke with him during a break at home in mid-April.Dr Joaquin Morante, ELAM Class of 2012: Pulmonologist, critical care attending physician at Jacobi Medical Center, New York City.","MEDICC Rev","Reed, Gail","32478713"],"abstract":["Speaking remotely with US graduates of Havana's Latin American School of Medicine (ELAM), I found them at work on hospital floors, in ICUs and health centers across the United States, putting their professional and personal commitment to the test against COVID-19. Nowhere was that more evident than in New York City, the disease's epicenter, where one grad told me virtually every hospital has at least one MD from the Cuban school, which has provided free 6-year medical training for some 30,000 doctors since the school's founding in 1999. The student body comes primarily from low- and middle-income countries worldwide, but Cuba also provided 200 US students with scholarships. One of them is Dr Joaquin Morante (ELAM Class of 2012), who did his medical residency in internal medicine, followed by fellowships in pulmonary disease and critical care medicine. Triple-licensed in internal medicine, pulmonary and critical care medicine, he is now an attending physician on staff at Jacobi Medical Center in The Bronx, one of New York City's public hospitals, and considered a 'hot spot' due to its COVID-19 caseload. I spoke with him during a break at home in mid-April.Dr Joaquin Morante, ELAM Class of 2012: Pulmonologist, critical care attending physician at Jacobi Medical Center, New York City."],"journal":"MEDICC Rev","authors":["Reed, Gail"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478713","source":"PubMed","week":"202023|Jun 01 - Jun 07","locations":["US","Havana","United States","New York","Cuban","Cuba","US","Bronx","New York's","New York","US"],"countries":["United States","Cuba"],"countries_codes":["USA|United States","CUB|Cuba"],"topics":["Prevention"],"weight":1,"_version_":1668437835127980032,"score":282.80313},{"pmid":32425653,"pmcid":"PMC7218555","title":"What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?","text":["What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?","Despite its current relatively low global share of cases and deaths in Africa compared to other regions, coronavirus disease 2019 (COVID-19) has the potential to trigger other larger crises in the region. This is due to the vulnerability of health and economic systems, coupled with the high burden of human immunodeficiency virus (HIV), tuberculosis (TB), and malaria. Here we examine the potential implications of COVID-19 on the control of these major epidemic diseases in Africa. We use current evidence on disease burden of HIV, TB, and malaria, and epidemic dynamics of COVID-19 in Africa, retrieved from the literature. Our analysis shows that the current measures to control COVID-19 neglect important and complex context-specific epidemiological, social, and economic realities in Africa. There is a similarity of clinical features of TB and malaria, with those used to track COVID-19 cases. This coupled with institutional mistrust and misinformation might result in many patients with clinical features similar to those of COVID-19 being hesitant to voluntarily seek care in a formal health facility. Furthermore, most people in productive age in Africa work in the informal sector, and most of those in the formal sector are underemployed. With the current measures to control COVID-19, these populations might face unprecedented difficulties to access essential services, mainly due to reduced ability of patients to support direct and indirect medical costs, and unavailability of transportation means to reach health facilities. Therefore, if not accompanied with appropriate economic and epidemiological considerations, we anticipate that these measures might result in unprecedented difficulties among vulnerable segments of society to access essential services, including antiretroviral and prophylactic drugs among people living with HIV and Acquired Immune Deficiency Syndrome, anti-tuberculosis drugs, and curative and preventive treatments for malaria among pregnant women and children. This might increase the propensity of patients taking substandard doses and/or medicines, which has the potential to compromise drug efficacy, and worsen health inequalities in the region. COVID-19 responses at country level should include measures to protect vulnerable and under-served segments of society.","Trop Med Health","Amimo, Floriano","Lambert, Ben","Magit, Anthony","32425653"],"abstract":["Despite its current relatively low global share of cases and deaths in Africa compared to other regions, coronavirus disease 2019 (COVID-19) has the potential to trigger other larger crises in the region. This is due to the vulnerability of health and economic systems, coupled with the high burden of human immunodeficiency virus (HIV), tuberculosis (TB), and malaria. Here we examine the potential implications of COVID-19 on the control of these major epidemic diseases in Africa. We use current evidence on disease burden of HIV, TB, and malaria, and epidemic dynamics of COVID-19 in Africa, retrieved from the literature. Our analysis shows that the current measures to control COVID-19 neglect important and complex context-specific epidemiological, social, and economic realities in Africa. There is a similarity of clinical features of TB and malaria, with those used to track COVID-19 cases. This coupled with institutional mistrust and misinformation might result in many patients with clinical features similar to those of COVID-19 being hesitant to voluntarily seek care in a formal health facility. Furthermore, most people in productive age in Africa work in the informal sector, and most of those in the formal sector are underemployed. With the current measures to control COVID-19, these populations might face unprecedented difficulties to access essential services, mainly due to reduced ability of patients to support direct and indirect medical costs, and unavailability of transportation means to reach health facilities. Therefore, if not accompanied with appropriate economic and epidemiological considerations, we anticipate that these measures might result in unprecedented difficulties among vulnerable segments of society to access essential services, including antiretroviral and prophylactic drugs among people living with HIV and Acquired Immune Deficiency Syndrome, anti-tuberculosis drugs, and curative and preventive treatments for malaria among pregnant women and children. This might increase the propensity of patients taking substandard doses and/or medicines, which has the potential to compromise drug efficacy, and worsen health inequalities in the region. COVID-19 responses at country level should include measures to protect vulnerable and under-served segments of society."],"journal":"Trop Med Health","authors":["Amimo, Floriano","Lambert, Ben","Magit, Anthony"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425653","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1186/s41182-020-00219-6","keywords":["africa","covid-19","hiv","health systems","malaria","tuberculosis"],"topics":["Prevention"],"weight":1,"_version_":1667252837767184385,"score":192.07378}]}